Gonadotropins as pharmacological agents in assisted reproductive technology and polycystic ovary syndrome

[1]  Bing He,et al.  Insulin resistance in polycystic ovary syndrome across various tissues: an updated review of pathogenesis, evaluation, and treatment , 2023, Journal of Ovarian Research.

[2]  Rulan Jiang,et al.  Effects of follicular output rate on cumulative clinical pregnancy rate and cumulative live birth rate in PCOS patients with different characteristics , 2022, Frontiers in Endocrinology.

[3]  Sui‐bing Miao,et al.  Pregnancy outcome and follow-up of offspring of donor oocytes recipient from PCOS patients , 2022, BMC Pregnancy and Childbirth.

[4]  F. Keleştimur,et al.  Differentiating Polycystic Ovary Syndrome from Adrenal Disorders , 2022, Diagnostics.

[5]  M. Sadeghi,et al.  Comparison of Triggering Final Oocyte Maturation with Follicle Stimulating Hormone Plus Human Chorionic Gonadotropin, versus Human Chorionic Gonadotropin Alonein Normoresponder Women Undergoing Intracytoplasmic Sperm Injection: A Randomized Clinical Trial , 2022, International journal of fertility & sterility.

[6]  Jing Wang,et al.  Does Serum LH Level Influence IVF Outcomes in Women with PCOS Undergoing GnRH-Antagonist Stimulation: A Novel Indicator , 2022, Journal of clinical medicine.

[7]  E. Gallardo,et al.  Follicular Fluid: A Powerful Tool for the Understanding and Diagnosis of Polycystic Ovary Syndrome , 2022, Biomedicines.

[8]  M. Abu,et al.  PCOS and Role of Cumulus Gene Expression in Assessing Oocytes Quality , 2022, Frontiers in Endocrinology.

[9]  Chi-Chiu Wang,et al.  Systematic review update and meta-analysis of randomized and non-randomized controlled trials of ovarian stimulation versus artificial cycle for endometrial preparation prior to frozen embryo transfer in women with polycystic ovary syndrome , 2022, Reproductive Biology and Endocrinology.

[10]  Shan Xiao,et al.  Association of antimüllerian hormone with polycystic ovarian syndrome phenotypes and pregnancy outcomes of in vitro fertilization cycles with fresh embryo transfer , 2022, BMC Pregnancy and Childbirth.

[11]  Z. Gajewski,et al.  Signaling mechanisms and their regulation during in vivo or in vitro maturation of mammalian oocytes , 2022, Reproductive Biology and Endocrinology.

[12]  V. Padmanabhan,et al.  Polycystic ovary syndrome as a plausible evolutionary outcome of metabolic adaptation , 2022, Reproductive Biology and Endocrinology.

[13]  Ping Li,et al.  Increased risk of abortion after frozen-thawed embryo transfer in women with polycystic ovary syndrome phenotypes A and D , 2021, Scientific reports.

[14]  K. Venkatesh,et al.  FSHR antagonists can trigger a PCOS-like state , 2021, Systems biology in reproductive medicine.

[15]  Dongzi Yang,et al.  Comparison of Cumulative Live Birth Rate Between Aged PCOS Women and Controls in IVF/ICSI Cycles , 2021, Frontiers in Endocrinology.

[16]  Han Zhao,et al.  Differential Lipidomic Characteristics of Children Born to Women with Polycystic Ovary Syndrome , 2021, Frontiers in Endocrinology.

[17]  A. Arcangeli,et al.  Transgenic mice overexpressing the LH receptor in the female reproductive system spontaneously develop endometrial tumour masses , 2021, Scientific Reports.

[18]  N. Raine-Fenning,et al.  Reduced FSH and LH action: implications for medically assisted reproduction , 2021, Human reproduction.

[19]  Chao Wang,et al.  Mechanisms of Oocyte Maturation and Related Epigenetic Regulation , 2021, Frontiers in Cell and Developmental Biology.

[20]  B. Tsang,et al.  The role of pituitary gonadotropins and intraovarian regulators in follicle development: A mini‐review , 2021, Reproductive medicine and biology.

[21]  C. Nachtergaele,et al.  Impact of myo-inositol treatment in women with polycystic ovary syndrome in assisted reproductive technologies , 2021, Reproductive Health.

[22]  R. Mohammadjafari,et al.  Evaluation of oocyte quality in Polycystic ovary syndrome patients undergoing ART cycles , 2021, Fertility Research and Practice.

[23]  T. G. Shrivastav,et al.  Direct impact of gonadotropins on glucose uptake and storage. , 2020, Metabolism: clinical and experimental.

[24]  H. Sangi-Haghpeykar,et al.  Embryos from polycystic ovary syndrome patients with hyperandrogenemia reach morula stage faster than controls , 2020, F&S reports.

[25]  N. Cui,et al.  Association between Body Mass Index and Reproductive Outcome in Women with Polycystic Ovary Syndrome Receiving IVF/ICSI-ET , 2020, BioMed research international.

[26]  R. Seemann,et al.  The Prevalence and Impact of Polycystic Ovary Syndrome in Recurrent Miscarriage: A Retrospective Cohort Study and Meta-Analysis , 2020, Journal of clinical medicine.

[27]  Z. Saadia.  Follicle Stimulating Hormone (LH: FSH) Ratio in Polycystic Ovary Syndrome (PCOS) - Obese vs. Non- Obese Women , 2020, Medical archives.

[28]  Xiuyu Hu,et al.  Pregnancy Outcomes of Women With Polycystic Ovary Syndrome for the First In Vitro Fertilization Treatment: A Retrospective Cohort Study With 7678 Patients , 2020, Frontiers in Endocrinology.

[29]  M. Urbanek,et al.  Distinct subtypes of polycystic ovary syndrome with novel genetic associations: An unsupervised, phenotypic clustering analysis , 2020, PLoS medicine.

[30]  Yangang Wang,et al.  Elevated circulating luteinizing hormone levels are associated with diabetic macroalbuminuria in Chinese men and postmenopausal women: A cross‐sectional study , 2020, Journal of diabetes.

[31]  Dongzi Yang,et al.  Does an FSH surge at the time of hCG trigger improve IVF/ICSI outcomes? A randomized, double-blinded, placebo-controlled study. , 2020, Human reproduction.

[32]  Dustin N. Hartzel,et al.  A genome-wide association study of polycystic ovary syndrome identified from electronic health records. , 2020, American journal of obstetrics and gynecology.

[33]  M. Tena-Sempere,et al.  Metabolic dysfunction in polycystic ovary syndrome: Pathogenic role of androgen excess and potential therapeutic strategies , 2020, Molecular metabolism.

[34]  J. Yeh,et al.  Luteinizing Hormone Action in Human Oocyte Maturation and Quality: Signaling Pathways, Regulation, and Clinical Impact , 2020, Reproductive Sciences.

[35]  Maliheh Afiat,et al.  Comparison of Oocyte and Embryo Quality in Women With Polycystic Ovary Syndrome and the Control Group Candidate for In Vitro Fertilization and Intracytoplasmic Sperm Injection , 2020, International Journal of Women's Health and Reproduction Sciences.

[36]  P. Humaidan,et al.  Low LH Level on the Day of GnRH Agonist Trigger Is Associated With Reduced Ongoing Pregnancy and Live Birth Rates and Increased Early Miscarriage Rates Following IVF/ICSI Treatment and Fresh Embryo Transfer , 2019, Front. Endocrinol..

[37]  W. Dhillo,et al.  FSH Requirements for Follicle Growth During Controlled Ovarian Stimulation , 2019, Front. Endocrinol..

[38]  Tingting Sha,et al.  A meta-analysis of pregnancy-related outcomes and complications in women with polycystic ovary syndrome undergoing IVF. , 2019, Reproductive biomedicine online.

[39]  J. Qiao,et al.  Transforming growth factor-β is involved in maintaining oocyte meiotic arrest by promoting natriuretic peptide type C expression in mouse granulosa cells , 2019, Cell Death & Disease.

[40]  B. Nikkhoo,et al.  COMPARISON OF MORPHOMETRIC AND MORPHOLOGY OOCYTES AFTER IN VITRO MATURATION BETWEEN HEALTHY WOMEN AND PATIENTS WITH POLYCYSTIC OVARIAN SYNDROME. , 2019, Acta endocrinologica.

[41]  S. Witchel,et al.  Polycystic Ovary Syndrome: Pathophysiology, Presentation, and Treatment With Emphasis on Adolescent Girls , 2019, Journal of the Endocrine Society.

[42]  Ngoc-Dan Thanh Cao,et al.  Does polycystic ovary syndrome affect morphokinetics or abnormalities in early embryonic development?☆ , 2019, European journal of obstetrics & gynecology and reproductive biology: X.

[43]  P. Crépieux,et al.  Molecular Mechanisms of Action of FSH , 2019, Front. Endocrinol..

[44]  Y. Wang,et al.  Influence of metabolic syndrome on female fertility and in vitro fertilization outcomes in PCOS women. , 2019, American journal of obstetrics and gynecology.

[45]  J. Laven.  Follicle Stimulating Hormone Receptor (FSHR) Polymorphisms and Polycystic Ovary Syndrome (PCOS) , 2019, Front. Endocrinol..

[46]  Michael D. Ober,et al.  Confirmation of Luteinizing Hormone (LH) in Living Human Vitreous and the Effect of LH Receptor Reduction on Murine Electroretinogram , 2018, Neuroscience.

[47]  Rong Li,et al.  Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome , 2018, Fertility and sterility.

[48]  C. Degli Esposti,et al.  Evidence for expression and functionality of FSH and LH/hCG receptors in human endometrium , 2018, Journal of assisted reproduction and genetics.

[49]  A. Genazzani,et al.  Kisspeptin and LH pulsatile temporal coupling in PCOS patients , 2018, Endocrine.

[50]  Peng-Hui Wang,et al.  Dual triggering with GnRH agonist plus hCG versus triggering with hCG alone for IVF/ICSI outcome in GnRH antagonist cycles: a systematic review and meta-analysis , 2018, Archives of Gynecology and Obstetrics.

[51]  B. Okopień,et al.  The Effect of Metformin on Serum Gonadotropin Levels in Postmenopausal Women with Diabetes and Prediabetes: A Pilot Study , 2018, Experimental and Clinical Endocrinology & Diabetes.

[52]  D. Abbott,et al.  Reproductive and metabolic determinants of granulosa cell dysfunction in normal-weight women with polycystic ovary syndrome. , 2018, Fertility and sterility.

[53]  H. Kishi,et al.  Expression of the gonadotropin receptors during follicular development , 2017, Reproductive medicine and biology.

[54]  S. Kim,et al.  Progesterone Suppression of Luteinizing Hormone Pulse Frequency in Adolescent Girls With Hyperandrogenism: Effects of Metformin , 2018, The Journal of clinical endocrinology and metabolism.

[55]  A. S. Mikhaylyukova,et al.  Improvement in quality of oocytes in polycystic ovarian syndrome in programs of in vitro fertilization , 2017, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[56]  Canquan Zhou,et al.  Early miscarriage rate in lean polycystic ovary syndrome women after euploid embryo transfer - a matched-pair study. , 2017, Reproductive biomedicine online.

[57]  D. Mata,et al.  A novel oocyte maturation trigger using 1500 IU of human chorionic gonadotropin plus 450 IU of follicle-stimulating hormone may decrease ovarian hyperstimulation syndrome across all in vitro fertilization stimulation protocols , 2017, Journal of Assisted Reproduction and Genetics.

[58]  A. Pinborg,et al.  GnRH antagonist versus long agonist protocols in IVF: a systematic review and meta-analysis accounting for patient type , 2017, Human reproduction update.

[59]  C. Stocco,et al.  IGF1R Expression in Ovarian Granulosa Cells Is Essential for Steroidogenesis, Follicle Survival, and Fertility in Female Mice , 2017, Endocrinology.

[60]  Y. Khramova,et al.  Influence of gonadotropins on ovarian follicle growth and development in vivo and in vitro , 2017, Zygote.

[61]  R. Yvinec,et al.  Human Luteinizing Hormone and Chorionic Gonadotropin Display Biased Agonism at the LH and LH/CG Receptors , 2017, Scientific Reports.

[62]  C. Rao.  Involvement of Luteinizing Hormone in Alzheimer Disease Development in Elderly Women , 2017, Reproductive Sciences.

[63]  Shee-Uan Chen,et al.  Frequency of low serum LH is associated with increased early pregnancy loss in IVF/ICSI cycles. , 2016, Reproductive biomedicine online.

[64]  D. Dewailly,et al.  Interactions between androgens, FSH, anti-Müllerian hormone and estradiol during folliculogenesis in the human normal and polycystic ovary. , 2016, Human reproduction update.

[65]  D. Ehrmann,et al.  The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited. , 2016, Endocrine reviews.

[66]  Hsin-Yang Li,et al.  The benefit of individualized low‐dose hCG support for high responders in GnRHa‐triggered IVF/ICSI cycles , 2016, Journal of the Chinese Medical Association : JCMA.

[67]  Ming-Hui Chen,et al.  Low aneuploidy rate in early pregnancy loss abortuses from patients with polycystic ovary syndrome. , 2016, Reproductive biomedicine online.

[68]  E. Turkbey,et al.  Bilateral Adrenal Hyperplasia as a Possible Mechanism for Hyperandrogenism in Women With Polycystic Ovary Syndrome. , 2016, The Journal of clinical endocrinology and metabolism.

[69]  V. Dinopoulou,et al.  Effect of recombinant-LH and hCG in the absence of FSH on in vitro maturation (IVM) fertilization and early embryonic development of mouse germinal vesicle (GV)-stage oocytes. , 2016, Reproductive biology.

[70]  P. Wimberger,et al.  Avoiding OHSS: Controlled Ovarian Low-Dose Stimulation in Women with PCOS , 2016, Geburtshilfe und Frauenheilkunde.

[71]  V. Kanamarlapudi,et al.  Luteinizing hormone/chorionic gonadotrophin receptor overexpressed in granulosa cells from polycystic ovary syndrome ovaries is functionally active. , 2016, Reproductive biomedicine online.

[72]  Qiyang Shou,et al.  Metformin improves hepatic IRS2/PI3K/Akt signaling in insulin-resistant rats of NASH and cirrhosis. , 2016, The Journal of endocrinology.

[73]  A. Moini,et al.  Assisted reproductive outcomes in women with different polycystic ovary syndrome phenotypes: the predictive value of anti-Müllerian hormone. , 2016, Reproductive biomedicine online.

[74]  M. Cardoso,et al.  Are Patients with Polycystic Ovarian Syndrome Ideal Candidates for Oocyte Donation? , 2016, BioMed research international.

[75]  J. Beavo,et al.  Luteinizing Hormone Causes Phosphorylation and Activation of the cGMP Phosphodiesterase PDE5 in Rat Ovarian Follicles, Contributing, Together with PDE1 Activity, to the Resumption of Meiosis , 2016, Biology of reproduction.

[76]  C. Acharya,et al.  Pregnancy outcomes decline with increasing body mass index: analysis of 239,127 fresh autologous in vitro fertilization cycles from the 2008-2010 Society for Assisted Reproductive Technology registry. , 2016, Fertility and sterility.

[77]  S. Tagliavini,et al.  Follicle-stimulating hormone potentiates the steroidogenic activity of chorionic gonadotropin and the anti-apoptotic activity of luteinizing hormone in human granulosa-lutein cells in vitro , 2016, Molecular and Cellular Endocrinology.

[78]  M. Conti,et al.  FSH Regulates mRNA Translation in Mouse Oocytes and Promotes Developmental Competence. , 2016, Endocrinology.

[79]  T. G. Shrivastav,et al.  FSH stimulates IRS-2 expression in human granulosa cells through cAMP/SP1, an inoperative FSH action in PCOS patients. , 2015, Cellular signalling.

[80]  N. Raine-Fenning,et al.  Maternal and neonatal outcomes in pregnant women with PCOS: comparison of different diagnostic definitions. , 2015, Human reproduction.

[81]  Bjarni V. Halldórsson,et al.  Causal mechanisms and balancing selection inferred from genetic associations with polycystic ovary syndrome , 2015, Nature Communications.

[82]  B. Wiesner,et al.  Differences in Signal Activation by LH and hCG are Mediated by the LH/CG Receptor’s Extracellular Hinge Region , 2015, Front. Endocrinol..

[83]  M. McCarthy,et al.  Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations , 2015, Nature Communications.

[84]  M. Paquet,et al.  Infertility in Female Mice with a Gain-of-Function Mutation in the Luteinizing Hormone Receptor Is Due to Irregular Estrous Cyclicity, Anovulation, Hormonal Alterations, and Polycystic Ovaries1 , 2015, Biology of reproduction.

[85]  P. Spritzer,et al.  Adipose tissue dysfunction, adipokines, and low-grade chronic inflammation in polycystic ovary syndrome. , 2015, Reproduction.

[86]  J. Kirwan,et al.  Pancreatic β-cell dysfunction in polycystic ovary syndrome: role of hyperglycemia-induced nuclear factor-κB activation and systemic inflammation. , 2015, American journal of physiology. Endocrinology and metabolism.

[87]  U. Knudsen,et al.  Unaltered timing of embryo development in women with polycystic ovarian syndrome (PCOS): a time-lapse study , 2015, Journal of Assisted Reproduction and Genetics.

[88]  G. Ning,et al.  High levels of chorionic gonadotrophin attenuate insulin sensitivity and promote inflammation in adipocytes. , 2015, Journal of molecular endocrinology.

[89]  F. Arechavaleta-Velasco,et al.  Adrenal androgen excess and body mass index in polycystic ovary syndrome. , 2015, The Journal of clinical endocrinology and metabolism.

[90]  Y. Combarnous,et al.  Structure–Function Relationships of Glycoprotein Hormones and Their Subunits’ Ancestors , 2015, Front. Endocrinol..

[91]  D. Dewailly,et al.  Is polycystic ovarian morphology related to a poor oocyte quality after controlled ovarian hyperstimulation for intracytoplasmic sperm injection? Results from a prospective, comparative study. , 2015, Fertility and sterility.

[92]  R. Sturmey,et al.  Human embryos from overweight and obese women display phenotypic and metabolic abnormalities. , 2015, Human reproduction.

[93]  P. Humaidan,et al.  A review of luteinising hormone and human chorionic gonadotropin when used in assisted reproductive technology , 2014, Reproductive Biology and Endocrinology.

[94]  P. Piomboni,et al.  Protein modification as oxidative stress marker in follicular fluid from women with polycystic ovary syndrome: the effect of inositol and metformin , 2014, Journal of Assisted Reproduction and Genetics.

[95]  S. Missmer,et al.  Effect of body mass index on in vitro fertilization outcomes in women with polycystic ovary syndrome. , 2014, American journal of obstetrics and gynecology.

[96]  M. L. Wissing,et al.  Impact of PCOS on early embryo cleavage kinetics. , 2014, Reproductive biomedicine online.

[97]  E. Baştu,et al.  Progression to impaired glucose tolerance or type 2 diabetes mellitus in polycystic ovary syndrome: a controlled follow-up study. , 2014, Fertility and sterility.

[98]  P. Spritzer.  Polycystic ovary syndrome: reviewing diagnosis and management of metabolic disturbances. , 2014, Arquivos brasileiros de endocrinologia e metabologia.

[99]  D. Adhikari,et al.  The regulation of maturation promoting factor during prophase I arrest and meiotic entry in mammalian oocytes , 2014, Molecular and Cellular Endocrinology.

[100]  J. Smitz,et al.  Luteinizing hormone and human chorionic gonadotropin: distinguishing unique physiologic roles , 2013, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[101]  NayanaH Patel,et al.  Luteinizing hormone and follicle stimulating hormone synergy: A review of role in controlled ovarian hyper-stimulation , 2013, Journal of human reproductive sciences.

[102]  G. Krause,et al.  Structural and functional plasticity of the luteinizing hormone/choriogonadotrophin receptor. , 2013, Human reproduction update.

[103]  S. Moon,et al.  Effects of Urinary and Recombinant Gonadotropins on In Vitro Maturation Outcomes of Mouse Preantral Follicles , 2013, Reproductive Sciences.

[104]  H. Cook-Andersen,et al.  Disordered follicle development , 2013, Molecular and Cellular Endocrinology.

[105]  B. Tsang,et al.  Dysregulation of ovarian follicular development in female rat: LH decreases FSH sensitivity during preantral-early antral transition. , 2013, Endocrinology.

[106]  R. Fanchin,et al.  Loss of LH-induced down-regulation of anti-Müllerian hormone receptor expression may contribute to anovulation in women with polycystic ovary syndrome. , 2013, Human reproduction.

[107]  E. Diamanti-Kandarakis,et al.  Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. , 2012, Endocrine reviews.

[108]  M. Simoni,et al.  LH and hCG Action on the Same Receptor Results in Quantitatively and Qualitatively Different Intracellular Signalling , 2012, PloS one.

[109]  Jong-Young Lee,et al.  Genome-wide association study identifies GYS2 as a novel genetic factor for polycystic ovary syndrome through obesity-related condition , 2012, Journal of Human Genetics.

[110]  Surleen Kaur,et al.  Differential gene expression in granulosa cells from polycystic ovary syndrome patients with and without insulin resistance: identification of susceptibility gene sets through network analysis. , 2012, The Journal of clinical endocrinology and metabolism.

[111]  Yuhua Shi,et al.  Genome-wide association study identifies eight new risk loci for polycystic ovary syndrome , 2012, Nature Genetics.

[112]  P. Haentjens,et al.  Obstetric outcome in donor oocyte pregnancies: a matched-pair analysis , 2012, Reproductive Biology and Endocrinology.

[113]  R. Chattopadhyay,et al.  Assessment of oocyte quality in polycystic ovarian syndrome and endometriosis by spindle imaging and reactive oxygen species levels in follicular fluid and its relationship with IVF-ET outcome , 2012, Journal of human reproductive sciences.

[114]  Enrico Carmina,et al.  Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. , 2012, Fertility and sterility.

[115]  S. Rice,et al.  Anti-Müllerian hormone reduces follicle sensitivity to follicle-stimulating hormone in human granulosa cells. , 2011, Fertility and sterility.

[116]  E. Jungheim,et al.  Polycystic ovary syndrome and maternal obesity affect oocyte size in in vitro fertilization/intracytoplasmic sperm injection cycles. , 2009, Fertility and sterility.

[117]  B. Zhang,et al.  Genome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3 , 2011, Nature Genetics.

[118]  Ayellet V. Segrè,et al.  Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis , 2010, Nature Genetics.

[119]  Ravinder J. Singh,et al.  Infants of women with polycystic ovary syndrome have lower cord blood androstenedione and estradiol levels. , 2010, The Journal of clinical endocrinology and metabolism.

[120]  H. Kanasaki,et al.  Effects of metformin administration on plasma gonadotropin levels in women with infertility, with an in vitro study of the direct effects on the pituitary gonadotrophs , 2010, Pituitary.

[121]  P. Navarro,et al.  Spindle and chromosome configurations of in vitro-matured oocytes from polycystic ovary syndrome and ovulatory infertile women: a pilot study , 2010, Journal of Assisted Reproduction and Genetics.

[122]  Alberto Revelli,et al.  Follicular fluid content and oocyte quality: from single biochemical markers to metabolomics , 2009, Reproductive biology and endocrinology : RB&E.

[123]  D. Ezcurra,et al.  Premature luteinization and in vitro fertilization outcome in gonadotropin/gonadotropin-releasing hormone antagonist cycles in women with polycystic ovary syndrome. , 2009, Fertility and sterility.

[124]  T. Liou,et al.  Inappropriate gonadotropin secretion in polycystic ovary syndrome. , 2009, Fertility and sterility.

[125]  S. Mudaliar,et al.  Polycystic ovary syndrome is associated with tissue-specific differences in insulin resistance. , 2009, The Journal of clinical endocrinology and metabolism.

[126]  D. Dewailly,et al.  Anti-Mullerian hormone, its receptor, FSH receptor, and androgen receptor genes are overexpressed by granulosa cells from stimulated follicles in women with polycystic ovary syndrome. , 2008, The Journal of clinical endocrinology and metabolism.

[127]  L. Rienzi,et al.  Significance of metaphase II human oocyte morphology on ICSI outcome. , 2008, Fertility and sterility.

[128]  O. Ozturk,et al.  Comparison of oocyte quality and intracytoplasmic sperm injection outcome in women with isolated polycystic ovaries or polycystic ovarian syndrome , 2008, Archives of Gynecology and Obstetrics.

[129]  D. Barad,et al.  Lack of association between polycystic ovary syndrome and embryonic aneuploidy. , 2007, Fertility and sterility.

[130]  R. Norman,et al.  Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. , 2006, The Journal of clinical endocrinology and metabolism.

[131]  J. Weck,et al.  Follicle-stimulating hormone/cAMP regulation of aromatase gene expression requires β-catenin , 2006, Proceedings of the National Academy of Sciences.

[132]  D. Boomsma,et al.  Heritability of polycystic ovary syndrome in a Dutch twin-family study. , 2006, The Journal of clinical endocrinology and metabolism.

[133]  E. Kilpatrick,et al.  The LH/FSH ratio has little use in diagnosing polycystic ovarian syndrome , 2006, Annals of clinical biochemistry.

[134]  D. Dewailly,et al.  Serum anti-Mullerian hormone as a surrogate for antral follicle count for definition of the polycystic ovary syndrome. , 2006, The Journal of clinical endocrinology and metabolism.

[135]  H. Yarali,et al.  Outcome of intracytoplasmic sperm injection in patients with polycystic ovary syndrome or isolated polycystic ovaries. , 2005, Fertility and sterility.

[136]  C. Rao,et al.  Dependence of Uterine Cyclooxygenase2 Expression on Luteinizing Hormone Signaling , 2005, Biology of reproduction.

[137]  Guillaume Smits,et al.  Premature ovarian aging in mice deficient for Gpr3. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[138]  K. Kind,et al.  Effects of recombinant human follicle-stimulating hormone on embryo development in mice. , 2005, American journal of physiology. Endocrinology and metabolism.

[139]  C. Rao,et al.  Targeted disruption of LH receptor gene revealed the importance of uterine LH signaling , 2005, Molecular and Cellular Endocrinology.

[140]  Suying Liu,et al.  Effect of midfollicular luteinizing hormone levels on ovarian response and pregnancy outcome in patients undergoing in vitro fertilization in a short-term protocol. , 2005, Fertility and sterility.

[141]  A. Evsikov,et al.  The Gs-Linked Receptor GPR3 Maintains Meiotic Arrest in Mammalian Oocytes , 2004, Science.

[142]  Chengyu Liu,et al.  Cyclic nucleotide phosphodiesterase 3A-deficient mice as a model of female infertility. , 2004, The Journal of clinical investigation.

[143]  M. Mäkinen,et al.  Selective ovary resistance to insulin signaling in women with polycystic ovary syndrome. , 2003, Fertility and sterility.

[144]  J. Belaisch-Allart,et al.  Qualité des ovocytes et embryons dans le syndrome des ovaires polykystiques , 2003 .

[145]  R. Baxter,et al.  Metformin rapidly increases insulin receptor activation in human liver and signals preferentially through insulin-receptor substrate-2. , 2003, The Journal of clinical endocrinology and metabolism.

[146]  J. Tesarik,et al.  Luteinizing hormone affects uterine receptivity independently of ovarian function. , 2003, Reproductive biomedicine online.

[147]  E. Milgrom,et al.  Follicle-stimulating hormone receptors in oocytes? , 2002, The Journal of clinical endocrinology and metabolism.

[148]  M. Shemesh.  Actions of gonadotrophins on the uterus. , 2001, Reproduction.

[149]  R. Azziz,et al.  Prevalence of polycystic ovary syndrome (PCOS) in first-degree relatives of patients with PCOS. , 2001, Fertility and sterility.

[150]  M. White,et al.  [Letters to nature] , 1975, Nature.

[151]  L. Layman.  Mutations in the follicle-stimulating hormone-beta (FSH beta) and FSH receptor genes in mice and humans. , 2000, Seminars in reproductive medicine.

[152]  G. Cognigni,et al.  Luteinizing hormone activity supplementation enhances follicle-stimulating hormone efficacy and improves ovulation induction outcome. , 1999, The Journal of clinical endocrinology and metabolism.

[153]  S. Roy,et al.  Activities of glucose metabolic enzymes in human preantral follicles: in vitro modulation by follicle-stimulating hormone, luteinizing hormone, epidermal growth factor, insulin-like growth factor I, and transforming growth factor beta1. , 1999, Biology of reproduction.

[154]  O. Ortmann,et al.  Oocyte quality and treatment outcome in intracytoplasmic sperm injection cycles of polycystic ovarian syndrome patients. , 1999, Human reproduction.

[155]  J. Liu,et al.  Timed analysis of the nuclear maturation of oocytes in early preantral mouse follicle culture supplemented with recombinant gonadotropin. , 1998, Fertility and sterility.

[156]  A. Gansmuller,et al.  Impairing follicle-stimulating hormone (FSH) signaling in vivo: targeted disruption of the FSH receptor leads to aberrant gametogenesis and hormonal imbalance. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[157]  J. Marshall,et al.  Polycystic ovary syndrome: evidence for reduced sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone. , 1998, The Journal of clinical endocrinology and metabolism.

[158]  P. Arner,et al.  Impaired adipocyte lipolysis in nonobese women with the polycystic ovary syndrome: a possible link to insulin resistance? , 1997, The Journal of clinical endocrinology and metabolism.

[159]  K. Sengoku,et al.  The chromosomal normality of unfertilized oocytes from patients with polycystic ovarian syndrome. , 1997, Human reproduction.

[160]  W. Collins,et al.  Hypersecretion of luteinizing hormone and ovarian steroids in women with recurrent early miscarriage. , 1993, Human reproduction.

[161]  K. Zuelke,et al.  Effects of luteinizing hormone on glucose metabolism in cumulus-enclosed bovine oocytes matured in vitro. , 1992, Endocrinology.

[162]  P. Vilja,et al.  Spontaneous luteinizing hormone surge and cleavage of in vitro fertilized embryos. , 1988, Fertility and sterility.